The US Senate has come together to pass a bill that aims to prevent pharma companies from filing multiple patents around biologic drugs as a way to delay biosimilar competitors. Lawmakers ...

I liked reading the always-excellent Rob Greenspoon’s post about five (almost) instant fixes to the patent system. The next U.S. Patent and Trademark Office (USPTO) Director would do well to ...